DisposeRx, Inc., manufacturer of the market leading at-home medication disposal solution, has in place a network of more than 1,000 pharmacies in New Jersey ready to meet the requirements of new legislation signed into law today. Read More »

DisposeRx—through its vast network of more than 2,000 pharmacies in Texas—is working to help pharmacists and pharmacies ensure compliance of HB 2088 through the availability of its safe, at-home disposal packets and patient education. Read More »

Statement emphasizes the pharmacist's role in educating patients, including the importance of disposing of unused medication Read More »

BIOC51 Antimicrobial Activity against Bacillus anthracis (Anthrax), Adding to the List of Bacteria Susceptible to the Company's Drug Candidate Read More »

Award Supports Advancement of BIOC51 Through Toxicology Studies in 2019 Read More »

Salix Pharmaceuticals, Ltd., one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. have received notice that the U.S. Food and Drug Administration has extended the PDUFA action date for its review of the New Drug Application for PLENVU®* (NER1006) by three months to May 13, 2018. Read More »

To combat severe pain for which alternative treatments fall short, BioDelivery Sciences International Inc.’s Belbuca (buprenorphine hydrochloride buccal film) product has just gained approval from Canada’s regulatory body, Health Canada, earning its Notice of Compliance. Read More »

Envisia Therapeutics has released an interim analysis on the second cohort of its ENV515 (travoprost XR) Phase 2 trial, which involves patients with glaucoma. Read More »

SPX-101, a new compound designed by Spyryx Biosciences, recently passed a Phase 1 study for the treatment of severe lung disease, including cystic fibrosis. Read More »

Mucodel Pharma, a private company based in Greensboro, North Carolina, that is dedicated to the development of improved rescue therapies to be administered oromucosally, has completed its Exonal (buccal naloxone) clinical study. Read More »

BioCryst Pharmaceuticals announced this week that the APeX-1 clinical trial involving BCX7353, which is designed to treat hereditary angioedema (HAE), has begun with the first patient being dosed. Read More »

Plastic manufacturer Technimark recently launched its new medical division, Technimark Healthcare. Read More »

Novozymes has announced that it will separate its biopharma activities to form an independent company. Read More »

The Board of Pharmacy will soon be ending its agreement with the North Carolina Pharmacy Recovery Network (NCPRN) and transitioning into a contract with the North Carolina Physicians Health Program (NCPHP) to act as a substance abuse monitoring and assessment program for pharmacists and industry personnel. Read More »

Xerox issued an update Oct. 13 on the strategic direction of its government health care business, focusing the implementation of its Health Enterprise Medicaid platform in California and Montana.Based on discussions with clients in California and Montana, Xerox said is likely it will not fully complete the implementation of the Health Enterprise Medicaid platform, its next-generation Medicaid Management Information System, in these states. Xerox said it expects to continue to process Medicaid cl Read More »

Xerox recently began working with MO HealthNet, Missouri’s state Medicaid division, to tackle the prescription-opioid drug abuse epidemic by using technology that increases the communication between physicians and pharmacists to ensure that opioids are prescribed and used safely. Read More »

Heat Biologics Inc. on Tuesday announced it enrolled the first patient in a Phase 1b clinical trial that examines the combination of its HS-110 therapeutic vaccine and the Bristol-Myers Squibb PD-1 inhibitor nivolumab (Opdivo) in non-small cell lung cancer. Read More »

Ateb, Inc., a provider of pharmacy-based patient-care solutions, launched its first branding campaign, "Driving Healthy Outcomes for Patients, Pharmacies and Payers," on Monday.The campaign indicates a fresh direction in the company's marketing efforts to create a brand identity. Read More »

Pharmacy leaders gathered on Thursday night at the sixth annual Next-Generation Pharmacist awards gala to celebrate the 2015 finalists and hear the winners announced. Read More »

The Hoke County Health Department announced on Friday it has automated pharmacy workflow with Patagonia Health’s built-in pharmacy app. Read More »